Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Wanhui Pharmaceutical is a specialized pharmaceutical company based in Beijing, China, and operates as a key subsidiary of China Resources Double-Crane Pharmaceutical. The company is primarily engaged in the research, development, and large-scale manufacturing of chemical generic drugs and traditional Chinese medicines. Its core therapeutic focus includes chronic conditions such as hypertension and diabetes, as well as pediatric and respiratory health. Wanhui maintains advanced production facilities that are fully GMP-certified, ensuring high-quality standards for its diverse portfolio of oral solid dosages. By leveraging the extensive distribution network of its parent company, Wanhui provides essential and affordable medications across the Chinese healthcare system. The company continues to modernize its product line through technical innovation and quality consistency evaluation of generic drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Wanhui Pharmaceutical Group.